Home/Filings/4/0001695028-25-000008
4//SEC Filing

Piscitelli Dominic 4

Accession 0001695028-25-000008

CIK 0001796280other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 7:19 PM ET

Size

14.1 KB

Accession

0001695028-25-000008

Insider Transaction Report

Form 4
Period: 2025-12-15
Piscitelli Dominic
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-15+29,33378,868 total
  • Sale

    Common Stock

    2025-12-16$9.06/sh10,720$97,12768,148 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-12-158,0000 total
    Common Stock (8,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-12-1510,00010,000 total
    Common Stock (10,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-12-1511,33322,667 total
    Common Stock (11,333 underlying)
Footnotes (7)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock.
  • [F2]Includes 1,218 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
  • [F3]Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
  • [F4]Represents the weighted average share price of an aggregate total of 10,720 shares sold in the price range of $9.0396 to $9.1953 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025.
  • [F6]1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026.
  • [F7]1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027.

Issuer

Oric Pharmaceuticals, Inc.

CIK 0001796280

Entity typeother

Related Parties

1
  • filerCIK 0001695028

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:19 PM ET
Size
14.1 KB